CoChat

CYP24A1 Mutations in a Cohort of Hypercalcemic Patients: Evidence for a Recessive Trait

Molin, A., Baudoin, R., Kaufmann, M., Souberbielle, J. C., Ryckewaert, A., Vantyghem, M. C., Eckart, P., Bacchetta, J., Deschenes, G., Kesler-Roussey, G., Coudray, N., Richard, N., Wraich, M., Bonafiglia, Q., Tiulpakov, A., Jones, G., Kottler, M.-L. · 2015 · The Journal of Clinical Endocrinology & Metabolism
Cited by 142

The DOI matches its Crossref record.

Abstract

CONTEXT: Loss-of-function mutations of CYP24A1 (which encodes the 25-OH-D3-24-hydroxylase) have recently been reported to cause hypercalcemia. OBJECTIVES: The aims of this study were: 1) to evaluate the frequency of CYP24A1 mutations in patients with medical history of hypercalcemia; 2) to show the clinical utility of a simultaneous assay of serum 25-hydroxyvitamin D3 (25-OH-D3) and 24,25-dihydroxyvitamin D3 (24,25-[OH]2D3) by liquid chromatography tandem mass spectrometry (LC-MS/MS); and 3) to investigate biochemical parameters in heterozygous gene carriers with CYP24A1 mutations. PATIENTS AND METHODS: We screened for CYP24A1 mutations in 72 patients with serum calcium levels > 2.6 mmol/L and PTH levels < 20 pg/mL and recruited 24 relatives after genetic counseling for subsequent investigations. Vitamin D metabolite concentrations were assessed in a subset of patients by LC-MS/MS and results expressed as a ratio (R) of 25-OH-D3:24,25-(OH)2D3. RESULTS: Twenty-five patients with hypercalcemia (35%) harbored CYP24A1 variations. Twenty (28%) had biallelic variations, mostly found in subjects with nephrocalcinosis or renal stones (19/20). Five patients, all neonates, were heterozygous, without renal disease. We describe 15 new variations leading to loss-of-function according to pathogenicity prediction programs, and we functionally characterized 5 of them in vitro. A dramatic increase of R, usually >80, was found in patients harboring biallelic mutations providing evidence in vivo for the loss of CYP24A1 activity. In contrast, R value remains <25 in patients without CYP24A1 mutations. Subjects carrying one mutant allele, hypercalcemic individuals, as well as gene-carrier relatives, had a detectable 24,25-(OH)2D3 level and R < 25, indicating normal 24-hydroxylase activity. CONCLUSION: CYP24A1 biallelic mutations are frequently found in patients presenting with hypercalcemia, low PTH, and renal disease. We confirm the accuracy and effectiveness of a novel blood test estimating the ratio between relevant vitamin D metabolites as a useful screening tool for CYP24A1 mutations. Haploinsufficiency is not associated with CYP24A1 deficiency.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2014-4387

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 142

Metadata

Authors
Molin, A., Baudoin, R., Kaufmann, M., Souberbielle, J. C., Ryckewaert, A., Vantyghem, M. C., Eckart, P., Bacchetta, J., Deschenes, G., Kesler-Roussey, G., Coudray, N., Richard, N., Wraich, M., Bonafiglia, Q., Tiulpakov, A., Jones, G., & Kottler, M.-L.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2015-10
Volume
100
Issue
10
Pages
E1343-E1352
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W1836955461
Cited by
142
References
0
FWCI
10.97
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: CYP24A1 Mutations in a Cohort of Hypercalcemic Patients: Evidence for a Recessive Trait. https://app.cochat.ai/papers/10.1210/jc.2014-4387
The paper
Molin, A., Baudoin, R., Kaufmann, M., Souberbielle, J. C., Ryckewaert, A., Vantyghem, M. C., Eckart, P., Bacchetta, J., Deschenes, G., Kesler-Roussey, G., Coudray, N., Richard, N., Wraich, M., Bonafiglia, Q., Tiulpakov, A., Jones, G., & Kottler, M.-L. (2015). CYP24A1 Mutations in a Cohort of Hypercalcemic Patients: Evidence for a Recessive Trait. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2014-4387

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.